Malaria — Worldwide/Unknown
A new drug to treat malaria has been given the green light by authorities in the United States. The medicine is specifically for the recurring form of malaria — caused by the parasite _Plasmodium vivax_ — which makes 8.5 million people ill each year. This type of malaria is a challenge to get rid of because it can remain dormant in the liver for years before reawakening many times.
Scientists have described tafenoquine as a “phenomenal achievement.” Regulators around the world will now
…
